☰

Louis Mansky - Publications

Affiliations: 
Molecular, Cellular, Developmental Biology and Genetics University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Virology Biology, Cell Biology, Biochemistry
Tree Info Similar researchers PubMed Report error

91 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Talledge N, Yang H, Shi K, Coray R, Yu G, Arndt WG, Meng S, Baxter GC, Mendonça LM, Castaño-Díez D, Aihara H, Mansky LM, Zhang W. HIV-2 Immature Particle Morphology Provides Insights into Gag Lattice Stability and Virus Maturation. Journal of Molecular Biology. 168143. PMID 37150290 DOI: 10.1016/j.jmb.2023.168143  0.46
2022 Angert I, Karuka SR, Mansky LM, Mueller JD. Partitioning of ribonucleoprotein complexes from the cellular actin cortex. Science Advances. 8: eabj3236. PMID 35984883 DOI: 10.1126/sciadv.abj3236  0.508
2022 Yang H, Talledge N, Arndt WG, Zhang W, Mansky LM. Human immunodeficiency virus type 2 capsid protein mutagenesis reveals amino acid residues important for virus particle assembly. Journal of Molecular Biology. 167753. PMID 35868362 DOI: 10.1016/j.jmb.2022.167753  0.466
2022 Meissner ME, Talledge N, Mansky LM. Molecular Biology and Diversification of Human Retroviruses. Frontiers in Virology. 2. PMID 35783361 DOI: 10.3389/fviro.2022.872599  0.454
2022 Herrmann D, Hanson HM, Zhou LW, Addabbo R, Willkomm NA, Angert I, Mueller JD, Mansky LM, Saad JS. Molecular Determinants of Human T-cell Leukemia Virus Type 1 Gag Targeting to the Plasma Membrane for Assembly. Journal of Molecular Biology. 167609. PMID 35490898 DOI: 10.1016/j.jmb.2022.167609  0.583
2021 Meissner ME, Willkomm NA, Lucas J, Arndt WG, Aitken SF, Julik EJ, Baliga S, Mansky LM. Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2. Journal of Molecular Biology. 434: 167355. PMID 34774569 DOI: 10.1016/j.jmb.2021.167355  0.527
2021 Meissner ME, Julik EJ, Badalamenti JP, Arndt WG, Mills LJ, Mansky LM. Development of a User-Friendly Pipeline for Mutational Analyses of HIV Using Ultra-Accurate Maximum-Depth Sequencing. Viruses. 13. PMID 34372543 DOI: 10.3390/v13071338  0.485
2021 Roth M, McDaniel YZ, Daly MB, Talledge N, Greggs WM, Patterson SE, Kim B, Mansky LM. Distinct antiretroviral mechanisms elicited by a viral mutagen. Journal of Molecular Biology. 167111. PMID 34153286 DOI: 10.1016/j.jmb.2021.167111  0.706
2021 Lockbaum GJ, Henes M, Talledge N, Rusere LN, Kosovrasti K, Nalivaika EA, Somasundaran M, Ali A, Mansky LM, Kurt Yilmaz N, Schiffer CA. Inhibiting HTLV-1 Protease: A Viable Antiviral Target. Acs Chemical Biology. PMID 33619959 DOI: 10.1021/acschembio.0c00975  0.429
2020 Harris M, Ratnapriya S, Chov A, Cervera H, Block A, Gu C, Talledge N, Mansky LM, Sodroski J, Herschhorn A. Slow Receptor Binding of the Noncytopathic HIV-2 Envs Is Balanced by Long-Lived Activation State and Efficient Fusion Activity. Cell Reports. 31: 107749. PMID 32521274 DOI: 10.1016/J.Celrep.2020.107749  0.433
2020 Addabbo RM, Kohler J, Angert I, Mansky LM, Mueller JD. Tracking Retrovirus Particles at Different Stages of the Viral Life Cycle using 3-Dimensional Superresolution Microscopy Biophysical Journal. 118: 147a. DOI: 10.1016/J.Bpj.2019.11.923  0.508
2020 Karuka SR, Angert I, Kohler J, Mansky LM, Mueller JD. Exclusion of RNA-Associated Proteins from the Cell Cortex Observed by Dual Color z-Scan Fluorescence Microscopy Biophysical Journal. 118: 463a. DOI: 10.1016/J.Bpj.2019.11.2575  0.501
2019 Angert I, Karuka SR, Hennen J, Chen Y, Albanesi JP, Mansky LM, Mueller JD. Sensitive Detection of Protein Binding to the Plasma Membrane with Dual-Color Z-Scan Fluorescence. Biophysical Journal. PMID 31870539 DOI: 10.1016/J.Bpj.2019.12.002  0.613
2019 Shepard C, Xu J, Holler J, Kim DH, Mansky LM, Schinazi RF, Kim B. Effect of induced dNTP pool imbalance on HIV-1 reverse transcription in macrophages. Retrovirology. 16: 29. PMID 31655617 DOI: 10.1186/S12977-019-0491-0  0.4
2019 McDaniel YZ, Patterson SE, Mansky LM. Distinct dual antiviral mechanism that enhances hepatitis B virus mutagenesis and reduces viral DNA synthesis. Antiviral Research. 104540. PMID 31247245 DOI: 10.1016/J.Antiviral.2019.104540  0.596
2019 Reddy Karuka S, Angert I, Kohler J, Gant Luxton G, Mansky LM, Mueller JD. Achieving Axial Super-Resolution with the Two-Photon Dual-Color Z-Scan Method Biophysical Journal. 116: 438a. DOI: 10.1016/J.Bpj.2018.11.2359  0.443
2019 Angert I, Kohler J, Reddy Karuka S, Meissner ME, Mansky LM, Mueller JD. Ultra-Sensitive Detection of Peripheral Membrane Protein Binding to the Plasma Membrane of Living Cells Biophysical Journal. 116: 283a. DOI: 10.1016/J.Bpj.2018.11.1532  0.506
2018 Eichorst JP, Chen Y, Mueller JD, Mansky LM. Distinct Pathway of Human T-Cell Leukemia Virus Type 1 Gag Punctum Biogenesis Provides New Insights into Enveloped Virus Assembly. Mbio. 9. PMID 30181245 DOI: 10.1128/Mbio.00758-18  0.715
2018 Maldonado JO, Mansky LM. The HIV-1 Reverse Transcriptase A62V Mutation Influences Replication Fidelity and Viral Fitness in the Context of Multi-Drug-Resistant Mutations. Viruses. 10. PMID 30029500 DOI: 10.3390/v10070376  0.406
2018 Maldonado JO, Mansky LM. The HIV-1 Reverse Transcriptase A62V Mutation Influences Replication Fidelity and Viral Fitness in the Context of Multi-Drug-Resistant Mutations. Viruses. 10. PMID 30029500 DOI: 10.3390/v10070376  0.406
2018 Martin JL, Mendonça L, Marusinec R, Zuczek J, Angert I, Blower RJ, Mueller JD, Perilla JR, Zhang W, Mansky LM. Critical Role of the HTLV-1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle Assembly. Journal of Virology. PMID 29695435 DOI: 10.1128/Jvi.00333-18  0.609
2018 Meissner ME, Baliga S, Roth M, Baller J, Mansky LM. A27 Exploring novel mechanisms of HIV-2 mutagenesis Virus Evolution. 4. DOI: 10.1093/ve/vey010.026  0.338
2017 Maldonado JO, Angert I, Cao S, Berk S, Zhang W, Mueller JD, Mansky LM. Perturbation of Human T-Cell Leukemia Virus Type 1 Particle Morphology by Differential Gag Co-Packaging. Viruses. 9. PMID 28753950 DOI: 10.3390/V9070191  0.608
2017 Rawson JMO, Gohl DM, Landman SR, Roth ME, Meissner ME, Peterson TS, Hodges JS, Beckman KB, Mansky LM. Single strand consensus sequencing reveals that HIV type but not subtype significantly impacts viral mutation frequencies and spectra. Journal of Molecular Biology. PMID 28502791 DOI: 10.1016/J.Jmb.2017.05.010  0.497
2017 Martin JL, Mendonça L, Angert I, Mueller JD, Zhang W, Mansky LM. Disparate contributions of human retrovirus capsid subdomains to Gag-Gag oligomerization, virus morphology and particle biogenesis. Journal of Virology. PMID 28446667 DOI: 10.1128/Jvi.00298-17  0.604
2016 Rawson JM, Roth ME, Xie J, Daly MB, Clouser CL, Landman SR, Reilly CS, Bonnac L, Kim B, Patterson SE, Mansky LM. Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase. Bioorganic & Medicinal Chemistry. PMID 27117260 DOI: 10.1016/J.Bmc.2016.03.052  0.685
2016 Daly MB, Roth ME, Bonnac L, Maldonado JO, Xie J, Clouser CL, Patterson SE, Kim B, Mansky LM. Dual anti-HIV mechanism of clofarabine. Retrovirology. 13: 20. PMID 27009333 DOI: 10.1186/S12977-016-0254-0  0.679
2016 Rawson JM, Daly MB, Xie J, Clouser CL, Landman SR, Reilly CS, Bonnac L, Kim B, Patterson SE, Mansky LM. 5-azacytidine enhances the mutagenesis of HIV-1 by reduction to 5-aza-2'-deoxycytidine. Antimicrobial Agents and Chemotherapy. PMID 26833151 DOI: 10.1128/Aac.03084-15  0.665
2016 Martin JL, Maldonado JO, Mueller JD, Zhang W, Mansky LM. Molecular Studies of HTLV-1 Replication: An Update. Viruses. 8. PMID 26828513 DOI: 10.3390/V8020031  0.637
2016 Rawson JM, Clouser CL, Mansky LM. Rapid Determination of HIV-1 Mutant Frequencies and Mutation Spectra Using an mCherry/EGFP Dual-Reporter Viral Vector. Methods in Molecular Biology (Clifton, N.J.). 1354: 71-88. PMID 26714706 DOI: 10.1007/978-1-4939-3046-3_6  0.423
2015 Zhang W, Cao S, Martin JL, Mueller JD, Mansky LM. Morphology and ultrastructure of retrovirus particles. Aims Biophysics. 2: 343-369. PMID 26448965 DOI: 10.3934/biophy.2015.3.343  0.595
2015 Rawson JM, Landman SR, Reilly CS, Bonnac L, Patterson SE, Mansky LM. Lack of Mutational Hot Spots during Decitabine-Mediated HIV-1 Mutagenesis. Antimicrobial Agents and Chemotherapy. 59: 6834-43. PMID 26282416 DOI: 10.1128/Aac.01644-15  0.694
2015 Rawson JM, Landman SR, Reilly CS, Mansky LM. HIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation. Retrovirology. 12: 60. PMID 26160407 DOI: 10.1186/S12977-015-0180-6  0.509
2015 Rawson JMO, Landman SR, Reilly CS, Mansky LM. HIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation Retrovirology. DOI: 10.1186/s12977-015-0180-6  0.444
2014 Beach LB, Rawson JM, Kim B, Patterson SE, Mansky LM. Novel inhibitors of human immunodeficiency virus type 2 infectivity. The Journal of General Virology. 95: 2778-83. PMID 25103850 DOI: 10.1099/Vir.0.069864-0  0.708
2014 Maldonado JO, Martin JL, Mueller JD, Zhang W, Mansky LM. New insights into retroviral Gag-Gag and Gag-membrane interactions. Frontiers in Microbiology. 5: 302. PMID 25009535 DOI: 10.3389/Fmicb.2014.00302  0.653
2014 Tabah AA, Tardif K, Mansky LM. Anti-HIV-1 activity of Trim 37. The Journal of General Virology. 95: 960-7. PMID 24317724 DOI: 10.1099/vir.0.057653-0  0.499
2014 Fogarty KH, Berk S, Grigsby IF, Chen Y, Mansky LM, Mueller JD. Interrelationship between cytoplasmic retroviral Gag concentration and Gag-membrane association. Journal of Molecular Biology. 426: 1611-24. PMID 24316368 DOI: 10.1016/J.Jmb.2013.11.025  0.83
2014 Sun M, Grigsby IF, Gorelick RJ, Mansky LM, Musier-Forsyth K. Retrovirus-specific differences in matrix and nucleocapsid protein-nucleic acid interactions: Implications for genomic RNA packaging Journal of Virology. 88: 1271-1280. PMID 24227839 DOI: 10.1128/Jvi.02151-13  0.387
2014 Dapp MJ, Bonnac L, Patterson SE, Mansky LM. Discovery of novel ribonucleoside analogs with activity against human immunodeficiency virus type 1. Journal of Virology. 88: 354-63. PMID 24155391 DOI: 10.1128/Jvi.02444-13  0.842
2014 Clouser CL, Bonnac L, Mansky LM, Patterson SE. Characterization of permeability, stability and anti-HIV-1 activity of decitabine and gemcitabine divalerate prodrugs. Antiviral Chemistry & Chemotherapy. 23: 223-30. PMID 23994876 DOI: 10.3851/Imp2682  0.676
2013 Rawson JM, Heineman RH, Beach LB, Martin JL, Schnettler EK, Dapp MJ, Patterson SE, Mansky LM. 5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors. Bioorganic & Medicinal Chemistry. 21: 7222-8. PMID 24120088 DOI: 10.1016/J.Bmc.2013.08.023  0.838
2013 Bonnac LF, Mansky LM, Patterson SE. Structure-activity relationships and design of viral mutagens and application to lethal mutagenesis. Journal of Medicinal Chemistry. 56: 9403-14. PMID 23914828 DOI: 10.1021/Jm400653J  0.582
2013 Holtz CM, Sadler HA, Mansky LM. APOBEC3G cytosine deamination hotspots are defined by both sequence context and single-stranded DNA secondary structure. Nucleic Acids Research. 41: 6139-48. PMID 23620282 DOI: 10.1093/Nar/Gkt246  0.775
2013 Holtz CM, Mansky LM. Variation of HIV-1 mutation spectra among cell types. Journal of Virology. 87: 5296-9. PMID 23449788 DOI: 10.1128/Jvi.03576-12  0.805
2013 Dapp MJ, Patterson SE, Mansky LM. Back to the future: revisiting HIV-1 lethal mutagenesis. Trends in Microbiology. 21: 56-62. PMID 23195922 DOI: 10.1016/J.Tim.2012.10.006  0.839
2013 Dapp MJ, Heineman RH, Mansky LM. Interrelationship between HIV-1 fitness and mutation rate. Journal of Molecular Biology. 425: 41-53. PMID 23084856 DOI: 10.1016/J.Jmb.2012.10.009  0.837
2012 Clouser CL, Chauhan J, Bess MA, van Oploo JL, Zhou D, Dimick-Gray S, Mansky LM, Patterson SE. Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine. Bioorganic & Medicinal Chemistry Letters. 22: 6642-6. PMID 23010273 DOI: 10.1016/J.Bmcl.2012.08.108  0.703
2012 Dapp MJ, Holtz CM, Mansky LM. Concomitant lethal mutagenesis of human immunodeficiency virus type 1. Journal of Molecular Biology. 419: 158-70. PMID 22426127 DOI: 10.1016/J.Jmb.2012.03.003  0.797
2012 Clouser CL, Holtz CM, Mullett M, Crankshaw DL, Briggs JE, O'Sullivan MG, Patterson SE, Mansky LM. Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1. Antimicrobial Agents and Chemotherapy. 56: 1942-8. PMID 22271861 DOI: 10.1128/Aac.06161-11  0.81
2012 Greggs WM, Clouser CL, Patterson SE, Mansky LM. Discovery of drugs that possess activity against feline leukemia virus. The Journal of General Virology. 93: 900-5. PMID 22258856 DOI: 10.1099/Vir.0.039909-0  0.658
2012 Guenzel CA, Hérate C, Le Rouzic E, Maidou-Peindara P, Sadler HA, Rouyez MC, Mansky LM, Benichou S. Recruitment of the nuclear form of uracil DNA glycosylase into virus particles participates in the full infectivity of HIV-1. Journal of Virology. 86: 2533-44. PMID 22171270 DOI: 10.1128/Jvi.05163-11  0.468
2012 Fogarty K, Chen Y, Grigsby I, MacDonald P, Smith E, Johnson J, Rawson J, Mansky L, Mueller J. Exploring the HTLV-1 Gag Membrane-Trafficking Pathway with Fluorescence Fluctuation Spectroscopy and Total Internal Reflection Fluorescence Microscopy Biophysical Journal. 102: 207a-208a. DOI: 10.1016/J.Bpj.2011.11.1133  0.797
2011 Fogarty KH, Zhang W, Grigsby IF, Johnson JL, Chen Y, Mueller JD, Mansky LM. New insights into HTLV-1 particle structure, assembly, and Gag-Gag interactions in living cells. Viruses. 3: 770-93. PMID 21994753 DOI: 10.3390/V3060770  0.814
2011 Greggs WM, Clouser CL, Patterson SE, Mansky LM. Broadening the use of antiretroviral therapy: the case for feline leukemia virus. Therapeutics and Clinical Risk Management. 7: 115-22. PMID 21479142 DOI: 10.2147/Tcrm.S17731  0.628
2011 Fogarty KH, Chen Y, Grigsby IF, Macdonald PJ, Smith EM, Johnson JL, Rawson JM, Mansky LM, Mueller JD. Characterization of cytoplasmic Gag-gag interactions by dual-color z-scan fluorescence fluctuation spectroscopy. Biophysical Journal. 100: 1587-95. PMID 21402042 DOI: 10.1016/J.Bpj.2011.02.008  0.818
2011 Clouser CL, Holtz CM, Mullett M, Crankshaw DL, Briggs JE, Chauhan J, VanHoutan IM, Patterson SE, Mansky LM. Analysis of the ex vivo and in vivo antiretroviral activity of gemcitabine. Plos One. 6: e15840. PMID 21264291 DOI: 10.1371/Journal.Pone.0015840  0.785
2011 Dorr CR, Yemets S, Kolomitsyna O, Krasutsky P, Mansky LM. Triterpene derivatives that inhibit human immunodeficiency virus type 1 replication. Bioorganic & Medicinal Chemistry Letters. 21: 542-5. PMID 21084190 DOI: 10.1016/J.Bmcl.2010.10.078  0.807
2011 Ni Z, Knorr DA, Clouser CL, Hexum MK, Southern P, Mansky LM, Park IH, Kaufman DS. Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms. Journal of Virology. 85: 43-50. PMID 20962093 DOI: 10.1128/Jvi.01774-10  0.424
2011 Fogarty KH, Chen Y, Grigsby IF, Macdonald PJ, Smith EM, Johnson JL, Rawson JM, Mueller JD, Mansky LM. Analysis of the HTLV-1 Gag assembly pathway by biophysical fluorescence Retrovirology. 8: A206. DOI: 10.1186/1742-4690-8-S1-A206  0.818
2011 Fogarty K, Johnson J, Grigsby I, MacDonald P, Chen Y, Rawson J, Mansky L, Mueller J. Brightness Analysis of Cytoplasmic HTLV-1 and HIV-1 Gag in the Presence of Membrane-Bound Gag Complexes by Dual-Color Z-Scan Fluorescence Fluctuation Spectroscopy Biophysical Journal. 100: 468a. DOI: 10.1016/J.Bpj.2010.12.2747  0.81
2010 Grigsby IF, Zhang W, Johnson JL, Fogarty KH, Chen Y, Rawson JM, Crosby AJ, Mueller JD, Mansky LM. Biophysical analysis of HTLV-1 particles reveals novel insights into particle morphology and Gag stochiometry. Retrovirology. 7: 75. PMID 20854688 DOI: 10.1186/1742-4690-7-75  0.789
2010 Clouser CL, Patterson SE, Mansky LM. Exploiting drug repositioning for discovery of a novel HIV combination therapy. Journal of Virology. 84: 9301-9. PMID 20610712 DOI: 10.1128/Jvi.01006-10  0.68
2010 Sadler HA, Stenglein MD, Harris RS, Mansky LM. APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis. Journal of Virology. 84: 7396-404. PMID 20463080 DOI: 10.1128/Jvi.00056-10  0.536
2010 Fogarty K, Grigsby I, Wang X, Chen Y, Rawson J, Mueller J, Mansky L. Characterization of Retroviral Gag Behavior in the Cytoplasm of Living Cells Using Fluorescence Fluctuation Spectroscopy Biophysical Journal. 98: 655a-656a. DOI: 10.1016/J.Bpj.2009.12.3595  0.843
2009 Dapp MJ, Clouser CL, Patterson S, Mansky LM. 5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1. Journal of Virology. 83: 11950-8. PMID 19726509 DOI: 10.1128/Jvi.01406-09  0.837
2009 Chen Y, Wu B, Musier-Forsyth K, Mansky LM, Mueller JD. Fluorescence fluctuation spectroscopy on viral-like particles reveals variable Gag stoichiometry Biophysical Journal. 96: 1961-1969. PMID 19254556 DOI: 10.1016/J.Bpj.2008.10.067  0.669
2009 Ni Z, Knorr DA, Clouser CL, Southern P, Mansky LM, Park I, Kaufman DS. Natural Killer Cells Derived From Human Pluripotent Stem Cells Provide a Novel Method to Treat HIV-1 Infection. Blood. 114: 280-280. DOI: 10.1182/Blood.V114.22.280.280  0.359
2007 Mbisa JL, Barr R, Thomas JA, Vandegraaff N, Dorweiler IJ, Svarovskaia ES, Brown WL, Mansky LM, Gorelick RJ, Harris RS, Engelman A, Pathak VK. Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration. Journal of Virology. 81: 7099-110. PMID 17428871 DOI: 10.1128/Jvi.00272-07  0.355
2006 Haché G, Mansky LM, Harris RS. Human APOBEC3 proteins, retrovirus restriction, and HIV drug resistance. Aids Reviews. 8: 148-57. PMID 17078485  0.415
2005 Chen R, Yokoyama M, Sato H, Reilly C, Mansky LM. Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies. Journal of Virology. 79: 12045-57. PMID 16140780 DOI: 10.1128/Jvi.79.18.12045-12057.2005  0.368
2005 Jewell NA, Mansky LM. Construction and characterization of deltaretrovirus indicator cell lines. Journal of Virological Methods. 123: 17-24. PMID 15582694 DOI: 10.1016/j.jviromet.2004.09.002  0.321
2005 Chen R, Quinones-Mateu ME, Mansky LM. HIV-1 mutagenesis during antiretroviral therapy: implications for successful drug treatment. Frontiers in Bioscience : a Journal and Virtual Library. 10: 743-50. PMID 15569614 DOI: 10.2741/1568  0.359
2004 Chen R, Quinones-Mateu ME, Mansky LM. Drug resistance, virus fitness and HIV-1 mutagenesis. Current Pharmaceutical Design. 10: 4065-70. PMID 15579088 DOI: 10.2174/1381612043382404  0.347
2004 Chen R, Le Rouzic E, Kearney JA, Mansky LM, Benichou S. Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages. The Journal of Biological Chemistry. 279: 28419-25. PMID 15096517 DOI: 10.1074/Jbc.M403875200  0.425
2004 Weiss KK, Chen R, Skasko M, Reynolds HM, Lee K, Bambara RA, Mansky LM, Kim B. A role for dNTP binding of human immunodeficiency virus type 1 reverse transcriptase in viral mutagenesis. Biochemistry. 43: 4490-500. PMID 15078095 DOI: 10.1021/Bi035258R  0.378
2003 Jewell NA, Chen R, Raices R, Mansky LM. Nucleoside reverse transcriptase inhibitors and HIV mutagenesis. The Journal of Antimicrobial Chemotherapy. 52: 547-50. PMID 12951341 DOI: 10.1093/Jac/Dkg387  0.389
2003 Mansky LM. Mutagenic outcome of combined antiviral drug treatment during human immunodeficiency virus type 1 replication. Virology. 307: 116-21. PMID 12667819 DOI: 10.1016/S0042-6822(02)00069-7  0.428
2003 Mansky LM, Le Rouzic E, Benichou S, Gajary LC. Influence of reverse transcriptase variants, drugs, and Vpr on human immunodeficiency virus type 1 mutant frequencies. Journal of Virology. 77: 2071-80. PMID 12525642 DOI: 10.1128/JVI.77.3.2071-2080.2003  0.478
2002 Mansky LM. HIV mutagenesis and the evolution of antiretroviral drug resistance. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 5: 219-23. PMID 12531178 DOI: 10.1016/S1368-7646(02)00118-8  0.337
2002 Mansky LM, Pearl DK, Gajary LC. Combination of drugs and drug-resistant reverse transcriptase results in a multiplicative increase of human immunodeficiency virus type 1 mutant frequencies. Journal of Virology. 76: 9253-9. PMID 12186909 DOI: 10.1128/Jvi.76.18.9253-9259.2002  0.38
2002 Wang H, Norris KM, Mansky LM. Analysis of bovine leukemia virus gag membrane targeting and late domain function. Journal of Virology. 76: 8485-93. PMID 12134053 DOI: 10.1128/Jvi.76.16.8485-8493.2002  0.338
2001 Mansky LM, Preveral S, Le Rouzic E, Bernard LC, Selig L, Depienne C, Benarous R, Benichou S. Interaction of human immunodeficiency virus type 1 Vpr with the HHR23A DNA repair protein does not correlate with multiple biological functions of Vpr. Virology. 282: 176-85. PMID 11259200 DOI: 10.1006/viro.2000.0791  0.467
2000 Mansky LM, Cunningham KS. Virus mutators and antimutatorsroles in evolution, pathogenesis and emergence Trends in Genetics. 16: 512-517. PMID 11074294 DOI: 10.1016/S0168-9525(00)02125-9  0.306
2000 Mansky LM, Bernard LC. 3'-Azido-3'-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1. Journal of Virology. 74: 9532-9. PMID 11000223 DOI: 10.1128/JVI.74.20.9532-9539.2000  0.449
2000 Mansky LM. In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy Journal of Virology. 74: 9525-9531. PMID 11000222 DOI: 10.1128/JVI.74.20.9525-9531.2000  0.428
2000 Mansky LM, Preveral S, Selig L, Benarous R, Benichou S. The interaction of Vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 in vivo mutation rate Journal of Virology. 74: 7039-7047. PMID 10888643 DOI: 10.1128/JVI.74.15.7039-7047.2000  0.484
1996 Mansky LM. Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell line Aids Research and Human Retroviruses. 12: 307-314. PMID 8906991  0.412
1996 Mansky LM. The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene Virology. 222: 391-400. PMID 8806523 DOI: 10.1006/viro.1996.0436  0.412
1995 Mansky LM, Temin HM. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase Journal of Virology. 69: 5087-5094. PMID 7541846 DOI: 10.1128/Jvi.69.8.5087-5094.1995  0.482
1994 Mansky LM, Temin HM. Lower mutation rate of bovine leukemia virus relative to that of spleen necrosis virus Journal of Virology. 68: 494-499. PMID 8254760 DOI: 10.1128/Jvi.68.1.494-499.1994  0.316
Show low-probability matches.